ENTITY
Hisamitsu Pharmaceutical Co

Hisamitsu Pharmaceutical Co (4530 JP)

53
Analysis
Health Care • Japan
HISAMITSU PHARMACEUTICAL CO., INC. produces and sells pharmaceutical products. The Company's main product is anti-inflammatory analgesic plasters and poultices sold under the brand name Salonpas. Hisamitsu Pharmaceutical exports its products to North America and Southeast Asia. The Company also researches and develops antibacterial products through its related company, RRF.
more
•21 Feb 2022 12:02

Insights from Data Mining Technical Publications - Plant Extracts Including from Cannabis

Herbal medicinal and nutraceutical extracts are seen as instruments to maintain health and treat some conditions. Cannabis, in particular, will see...

Logo
320 Views
Share
bullish•Sawai Pharmaceutical
•27 Jan 2022 01:00

Sawai Pharmaceutical: Big Capacity Expansion Planned Amid Supply Shortages to Drive Market Share

By chalking out a huge capacity expansion plan and new product launches, Sawai is expected to enhance market share in Japan generic drug market,...

Logo
313 Views
Share
•14 Dec 2021 23:03

Hisamitsu Pharmaceutical (4530 JP): Focus Shifts to ADHD Treatment Patch and Other Upcoming Launches

While our bear case still holds good for the company, near-term focus is now shifting to new launches and upcoming approvals. Hisamitsu is expected...

Logo
359 Views
Share
•10 Oct 2021 22:30

Hisamitsu Pharmaceutical (4530 JP): Avoid as More Pain Ahead

Shares of Hisamitsu is trading near 52-week low. However, investors should avoid the stock ahead of its Q2 results announcement due to near-term...

Logo
406 Views
Share
bullish•SG Holdings
•07 Aug 2021 11:41

JPX Nikkei 400 Index Rebalance: Big Turnover, Big Impact & A Market Consultation

There are 41 adds and 40 deletes for the JPX NK 400 Index. One-way turnover is high at 8.16% and will result in a trade of JPY 468bn. There will be...

Logo
578 Views
Share
x